domingo, 29 de enero de 2017

The role of pharmacogenetics in the new ESMO colorectal cancer guidelines. - PubMed - NCBI

The role of pharmacogenetics in the new ESMO colorectal cancer guidelines. - PubMed - NCBI



 2017 Feb;18(3):197-200. doi: 10.2217/pgs-2016-0191. Epub 2017 Jan 23.

The role of pharmacogenetics in the new ESMO colorectal cancer guidelines.

KEYWORDS:

DPD; ERCC1; UGT; colorectal cancer; pharmacogenetic

PMID:
 
28112993
 
DOI:
 
10.2217/pgs-2016-0191

[PubMed - in process] 
Free full text

No hay comentarios:

Publicar un comentario